Study Subject Participation Status | Therapeutic procedure Lymphoma | CALGB Clinical Trial Specified | Treatment Course New Lymphoma
Item
participant must be enrolled in a lymphoma therapy study at the nih clinical center or be enrolled in the calgb 50303 study at another site or undergoing a new course of treatment of lymphoma at another facility.
boolean
C2348568 (UMLS CUI [1])
C0087111 (UMLS CUI [2,1])
C0024299 (UMLS CUI [2,2])
C1516238 (UMLS CUI [3,1])
C0008976 (UMLS CUI [3,2])
C0205369 (UMLS CUI [3,3])
C0087111 (UMLS CUI [4,1])
C0750729 (UMLS CUI [4,2])
C0205314 (UMLS CUI [4,3])
C0024299 (UMLS CUI [4,4])
Clinical course Consistent with Lymphoma | Documentation Lymphoma
Item
participants must have a clinical course consistent with lymphoma and have available documentation of lymphoma from either the nci or from an outside pathology laboratory.
boolean
C0449259 (UMLS CUI [1,1])
C0332290 (UMLS CUI [1,2])
C0024299 (UMLS CUI [1,3])
C0920316 (UMLS CUI [2,1])
C0024299 (UMLS CUI [2,2])
Age
Item
participant must be 18 years or older.
boolean
C0001779 (UMLS CUI [1])
ECOG performance status
Item
ecog performance score of 0 or 1.
boolean
C1520224 (UMLS CUI [1])
Informed Consent
Item
ability to provide informed consent. all patients must sign a document of informed consent indicating their understanding of the investigational nature and risks of the study before any protocol related studies are performed.
boolean
C0021430 (UMLS CUI [1])
Enrollment Response Early Arm
Item
for subjects enrolling in early response arm
boolean
C1516879 (UMLS CUI [1,1])
C1704632 (UMLS CUI [1,2])
C1279919 (UMLS CUI [1,3])
C1522541 (UMLS CUI [1,4])
Study Subject Participation Status | CALGB Clinical Trial Specified | Therapeutic procedure Lymphoma | Treatment Course New Lymphoma
Item
must be enrolled in calgb 50303 or a lymphoma therapy study at the nih clinical center or undergoing a new course of treatment of lymphoma at another facility
boolean
C2348568 (UMLS CUI [1])
C1516238 (UMLS CUI [2,1])
C0008976 (UMLS CUI [2,2])
C0205369 (UMLS CUI [2,3])
C0087111 (UMLS CUI [3,1])
C0024299 (UMLS CUI [3,2])
C0087111 (UMLS CUI [4,1])
C0750729 (UMLS CUI [4,2])
C0205314 (UMLS CUI [4,3])
C0024299 (UMLS CUI [4,4])
Absence Therapeutic procedure Lymphoma Current | Absence Therapeutic procedure Recurrent Lymphoma
Item
must not have begun lymphoma therapy for this tumor occurrence/ relapse
boolean
C0332197 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0024299 (UMLS CUI [1,3])
C0521116 (UMLS CUI [1,4])
C0332197 (UMLS CUI [2,1])
C0087111 (UMLS CUI [2,2])
C4525062 (UMLS CUI [2,3])
Eligibility Independent of Prior Therapy
Item
prior completed therapy does not affect eligibility
boolean
C1548635 (UMLS CUI [1,1])
C0332291 (UMLS CUI [1,2])
C1514463 (UMLS CUI [1,3])
Enrollment Protocol Treatment Arm | Tumor Mass Residual FDG Avidity
Item
for subjects enrolling in the residual fdg avid mass arm
boolean
C1516879 (UMLS CUI [1,1])
C1522541 (UMLS CUI [1,2])
C3273930 (UMLS CUI [2,1])
C1609982 (UMLS CUI [2,2])
C0046056 (UMLS CUI [2,3])
C1510996 (UMLS CUI [2,4])
Tumor Mass Residual Size | FDG-PET Positive
Item
must have a residual fdg pet positive mass greater than equal to 1cm, with uptake greater than that of mediastinal blood pool.
boolean
C3273930 (UMLS CUI [1,1])
C1609982 (UMLS CUI [1,2])
C0456389 (UMLS CUI [1,3])
C3641247 (UMLS CUI [2,1])
C1514241 (UMLS CUI [2,2])
FDG-PET and CT Scan Repeat | FDG-PET Original Inadequate
Item
participant will undergo a repeat fdg pet/ct scan if the original fdg/pet imaging performed at an outside institution is not of adequate imaging quality for subjects enrolling in the residual fdg mass arm.
boolean
C4521453 (UMLS CUI [1,1])
C0205341 (UMLS CUI [1,2])
C3641247 (UMLS CUI [2,1])
C0205313 (UMLS CUI [2,2])
C0205412 (UMLS CUI [2,3])
Hypersensitivity 18F-FLT
Item
known allergy to fluorothymidine.
boolean
C0020517 (UMLS CUI [1,1])
C1432709 (UMLS CUI [1,2])
Delay Standard of Care Scheduled
Item
participants for whom enrollment would significantly delay (greater than 2 weeks) the scheduled standard of care therapy.
boolean
C0205421 (UMLS CUI [1,1])
C2936643 (UMLS CUI [1,2])
C0205539 (UMLS CUI [1,3])
Comorbidity Interferes with Interventional procedure | Mental condition Interferes with Interventional procedure | Comorbidity Interferes with Research results | Mental condition Interferes with Research results
Item
participants with any coexisting medical or psychiatric condition that is likely to interfere with study procedures and/or results are excluded.
boolean
C0009488 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C0184661 (UMLS CUI [1,3])
C3840291 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C0184661 (UMLS CUI [2,3])
C0009488 (UMLS CUI [3,1])
C0521102 (UMLS CUI [3,2])
C0683954 (UMLS CUI [3,3])
C3840291 (UMLS CUI [4,1])
C0521102 (UMLS CUI [4,2])
C0683954 (UMLS CUI [4,3])
Claustrophobia Severe | Anti-Anxiety Agents Oral Absent | Body Weight Very high
Item
participants with severe claustrophobia not relieved by oral anxiolytic medication or patients weighing greater than 136 kg (weight limit for scanner table).
boolean
C0008909 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0040616 (UMLS CUI [2,1])
C1527415 (UMLS CUI [2,2])
C0332197 (UMLS CUI [2,3])
C0005910 (UMLS CUI [3,1])
C0442804 (UMLS CUI [3,2])
Other medical condition Ineligibility Interventional procedure
Item
other medical conditions deemed by the pi or associates to make the patient ineligible for protocol procedures.
boolean
C3843040 (UMLS CUI [1,1])
C1512714 (UMLS CUI [1,2])
C0184661 (UMLS CUI [1,3])